The Promise and Reality of NGTs

Our Transformation Talks Summer Special is here!

Next Generation Therapies (NGTs) currently in development will deliver treatments that address the underlying cause of diseases, disrupt the biopharmaceutical environment, and offer a life-long solution to patients. They create unprecedented opportunities for patients and will be measurable in lives saved, disabilities reduced, and overall quality of life improvements. However, along with these benefits come unprecedented challenges for insurance coverage, reimbursement, and payment.

Tune in to learn about risks and challenges in developing NGTs, bringing them to the market, and how NGTs can change patients’ lives once their value is understood and correctly attributed by the decision makers / payers.

This special episode is not only be available in audio format but also in video and features a stellar group of guests:

• Andrea Mantovani – Vice President, Global Market Access and Pricing, Alira Health
• Oswald Bentinck – Vice President – Head of Market Access EMEA, Novartis Gene Therapies
• Pietro Sternini – Executive Director, Gene Therapy Market Access & Marketing Lead, EMEA, Astellas Gene Therapies

Watch the episode “The Promise and Reality of NGTs”:

Listen to the episode:

The episode “The Promise and Reality of Next Generation Therapies” is also available on the following platforms: